Parkinson’s Disease Therapeutics Market: Assessing the Impact of Next-Generation Disease-Modifying Drugs.
The Crucial Shift in Research Focus Towards Underlying Pathology and Progression The global research community and pharmaceutical industry are collectively recognizing the limitations of current Parkinson's disease treatments, which are predominantly symptomatic. Historically, therapeutics have focused on replenishing dopamine levels to control motor functions like tremor and rigidity. However,...
0 Comments 0 Shares 158 Views 0 Reviews